Creyos Company Profile

Background

Overview

Creyos is a healthcare technology company specializing in cognitive and behavioral health assessments. Founded in 2015 by neuroscientist Professor Adrian Owen and business leader Marc Lipton, Creyos aims to revolutionize the evaluation and monitoring of brain health through scientifically validated, accessible, and efficient digital tools. The company is headquartered in Toronto, Canada.

Mission and Vision

Creyos is dedicated to providing healthcare providers with objective, data-driven insights into patient brain health, enabling more accurate diagnoses, personalized treatment plans, and improved patient outcomes. The company's vision is to make understanding brain health as straightforward as telling time, ensuring that clinicians have the tools to assess cognitive and behavioral health with precision and ease.

Primary Area of Focus

Creyos focuses on developing digital cognitive assessment platforms that measure various aspects of cognitive function, including memory, attention, reasoning, and executive function. These assessments are designed to aid in the early detection, monitoring, and management of conditions such as dementia, ADHD, concussion, and other mental health disorders.

Industry Significance

In an era where mental health awareness is paramount, Creyos stands out by offering scientifically validated, user-friendly tools that bridge the gap between traditional cognitive assessments and modern healthcare needs. The company's platform is utilized by thousands of healthcare providers worldwide, supporting evidence-based decision-making and enhancing the quality of care.

Key Strategic Focus

Core Objectives

Early Detection: Implement tools that facilitate the timely identification of cognitive impairments, enabling prompt intervention.

Accessibility: Ensure that cognitive assessments are user-friendly and accessible to diverse patient populations, including those with limited technological proficiency.

Integration: Develop solutions that seamlessly integrate into existing clinical workflows, minimizing administrative burden for healthcare providers.

Specific Areas of Specialization

Cognitive Assessments: Offer a range of tests measuring domains such as short-term memory, attention, decision-making capacity, and executive function.

Behavioral Health Screeners: Provide digitized questionnaires to evaluate mental wellness and behavioral health, supporting comprehensive patient assessments.

Condition-Specific Protocols: Develop ready-made protocols combining cognitive tasks and behavioral health questionnaires tailored for conditions like ADHD and mild cognitive impairment.

Key Technologies Utilized

Digital Cognitive Tasks: Web-based assessments derived from validated pen-and-paper tests, enabling efficient and accurate measurement of cognitive functions.

Behavioral Health Screeners: Digitized questionnaires that automatically tabulate results, providing quick insights into mental wellness and behavioral health.

Data Analytics: Advanced analytics to generate clear, actionable reports that inform clinical decision-making.

Primary Markets Targeted

Healthcare Providers: Clinics, hospitals, and private practices seeking reliable tools for cognitive and behavioral health assessment.

Researchers: Academic and commercial entities conducting studies on cognition and mental health.

Patients: Individuals requiring cognitive assessments for conditions such as dementia, ADHD, and concussion.

Financials and Funding

Funding History

July 2023: Secured a $1.5 million debt financing investment from FedDev Ontario to accelerate the adoption of its platform.

Utilization of Capital

The funds are intended to support the expansion of Creyos's platform capabilities, enhance research and development efforts, and broaden the company's reach within the healthcare sector.

Pipeline Development

Key Pipeline Candidates

Creyos is continually developing and refining its suite of cognitive and behavioral health assessments, focusing on:

ADHD Assessment Tools: Enhancing precision in ADHD detection through comprehensive cognitive tests and symptom questionnaires.

Dementia Screening Protocols: Developing condition-specific protocols to aid in the early detection and monitoring of dementia-related cognitive decline.

Stages of Development

Creyos's assessments are in various stages, from initial development to deployment in clinical settings, with ongoing updates to improve accuracy and user experience.

Target Conditions

ADHD: Attention Deficit Hyperactivity Disorder

Dementia: Including Alzheimer's disease and other neurodegenerative conditions

Concussion: Traumatic brain injuries affecting cognitive function

Other Mental Health Disorders: Conditions impacting cognitive and behavioral health

Anticipated Milestones

2025: Launch of enhanced ADHD assessment tools with improved diagnostic precision.

2026: Introduction of advanced dementia screening protocols for early detection and monitoring.

Technological Platform and Innovation

Proprietary Technologies

Digital Cognitive Tasks: Online assessments measuring specific cognitive domains, providing real-time, quantifiable insights.

Behavioral Health Screeners: Digitized questionnaires that streamline the assessment process and deliver immediate results.

Significant Scientific Methods

Neuroimaging Techniques: Utilizing data from PET and fMRI studies to inform the development of cognitive tasks.

Large-Scale Online Studies: Conducting extensive online research to validate assessment tools and establish normative data.

Leadership Team

Marc Lipton: Chief Executive Officer

Background: Experienced business leader with a focus on healthcare innovation.

Role: Oversees strategic direction and operations of Creyos.

Professor Adrian Owen, PhD, OBE: Chief Scientific Officer

Background: Renowned neuroscientist specializing in cognitive neuroscience and neuroimaging.

Role: Leads scientific research and development of assessment tools.

Alex Sherrington: Chief Financial Officer

Background: Financial strategist with experience in scaling technology companies.

Role: Manages financial operations and funding strategies.

Faraz Shafaghi: Chief Product and Customer Experience Officer

Background: Expertise in product development and customer engagement.

Role: Oversees product strategy and ensures customer satisfaction.

Michelle Dillon: Vice President, People and Culture

Background: Human resources leader with a focus on organizational development.

Role: Drives talent acquisition and fosters company culture.

Jamie Zuckier: Chief Revenue Officer

Background: Sales and marketing professional with a track record in revenue growth.

Role: Leads revenue generation strategies and partnerships.

Erin Smith: Chief Marketing Officer

Background: Marketing strategist with experience in healthcare sectors.

Role: Manages brand development and marketing initiatives.

Risto Juola: Chief Technology Officer

Background: Technology expert specializing in software development and infrastructure.

Role: Oversees technological innovation and platform development.

Mike Battista: Director, Science and Research

Background: Scientist with expertise in cognitive neuroscience research.

Role: Leads scientific research and validation of assessment tools.

Spencer Yeung: Director, Sales

Background: Sales leader with experience in healthcare technology.

Role: Drives sales strategies and customer acquisition.

Ming Li: Director, Finance

Background: Financial analyst with a focus on corporate finance.

Role: Manages financial planning and analysis.

Slava Pocheptsov: Director, Engineering

Background: Software engineer with experience in scalable systems.

Role: Leads engineering teams in platform development.

Leadership Changes

As of August 2025, there have been no publicly disclosed significant changes or appointments within Creyos's leadership team.

Competitor Profile

Market Insights and Dynamics

creyos